Diagnosis and treatment in adult patients with C3 glomerulopathy in Japan: a real-world survey
This survey analysis explored the current status in diagnosis and management of patients with C3G in Japan. The lack of specific treatments emphasizes the need for novel targeted therapies addressing the root cause of C3G.
Authors
- Kazuma Iekushi (ORCID: https://orcid.org/0000-0002-8056-4281)
- Shunsuke Eguchi (ORCID: https://orcid.org/0000-0001-9512-1339)
- Serge Smeets
- Yutaro Kotobuki
- Toshinaga Tsuji (ORCID: https://orcid.org/0000-0003-3685-0763)
- Susanna Libby
- Naoki Nakagawa (ORCID: https://orcid.org/0000-0002-5398-3667)
- Michel Kroes (ORCID: https://orcid.org/0000-0002-1381-9184)
- Alice Simons
- Raisa Sidhu
Institutions
- Novartis (Switzerland) (CH)
- Asahikawa Medical University (JP)
- Adelphi Group (United Kingdom) (GB)
- Novartis (Japan) (JP)
Publication Details
- Journal
- Clinical and Experimental Nephrology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1007/s10157-025-02779-5
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novartis Pharma